EP Global Communications Inc fka EPGL

[Ocean View]

S&P CAPITAL IQ KEEPS BUY RECOMMENDATION ON SHARES OF THE COOPER COMPANIES
5 days 23 hours 57 minutes ago - S&P Capital IQ

We reduce our 12-month target by $18 to $191, assuming a P/E (22X) to growth (11%) of 2.0X, in line with medical device peers, applied to our FY 16 (Oct.) EPS estimate of $8.70. We reduce our FY 15 EPS estimate $0.02 to $$7.55. Jul-Q adjusted EPS of $1.97 vs. $1.90 is $0.01 below our estimate. We are disappointed as demand in the US was softer than we expected, despite strength in EMEA and Asia Pacific. But, we believe the company is well positioned to benefit in the long term on expected market share gains as it rolls out new silicone hydrogel products in the US and in Europe.

In other reading I think is hydrogel is already produced. So the "new" products will have to left to interpretation for the moment.